相关实验视频
Updated: Jan 12, 2026

05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
5.5K
纳米材料在糖尿病并发症管理中的应用
Xianjun Luo1, Nuonan Li1, Xiaoyong Zhu2
1Department of Cardiology, Jiujiang University Affiliated Hospital, Jiujiang, Jiangxi, China; Graduate Department, Gannan Medical University, Ganzhou, Jiangxi, China.
Colloids and surfaces. B, Biointerfaces
|November 2, 2025
概括
纳米材料通过向脏病和视网膜病变等并发症,为糖尿病治疗提供了新的途径. 这些先进的材料改善了糖尿病患者的药物输送和治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病 (DM) 是一种以高血糖症为特征的代谢障碍,导致糖尿病病 (DN),心血管疾病 (CVD) 和视网膜病变等严重并发症.
- 现有的治疗方法在有效管理这些广泛的糖尿病并发症方面面临挑战.
研究的目的:
- 将纳米材料 (NM) 分类并探索它们在治疗糖尿病并发症中的应用.
- 突出 NMs 在先进的药物输送系统中的作用,以提高生物相容性和生物可用性.
主要方法:
- 将纳米材料分为有机 (聚合物,脂质,蛋白质) 和无机 (金属,氧化物,陶,碳基) 的类别.
- 对利用纳米材料进行向治疗的药物输送系统的审查.
- 分析纳米材料在特定糖尿病并发症中的应用.
主要成果:
- 纳米材料在治疗糖尿病并发症方面具有显著的潜力,包括DN,视网膜病变,糖尿病足,心血管疾病和神经病变.
- NMs促进向药物递送,抗纤维化,抗炎作用,光动力学疗法,伤口愈合和心肌修复.
- 结合NMS的药物输送系统提供了更好的疗效和生物可用性.
结论:
- 纳米材料代表了一种有希望的,创新的方法来管理糖尿病及其相关并发症.
- NMs的独特特性增强治疗策略,可能改善患者的生活质量.
相关概念视频
Diabetes: Management and Pharmacotherapy
856
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
856
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
571
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
571

